Form 4: MaxLinear CFO Sells 44,929 Shares Under 10b5-1 Plan

MaxLinear's Chief Financial Officer, Steven G. Litchfield, sold a total of 44,929 shares of common stock over three days in early March 2026 under a pre-arranged trading plan, reducing his beneficial ownership to 343,435 shares.

Summary

• Steven G. Litchfield, MaxLinear's Chief Financial Officer and Chief Corporate Strategy Officer, reported the sale of 44,929 shares of common stock.
• The transactions occurred on March 4, 5, and 6, 2026, and were executed under a Rule 10b5-1 pre-arranged trading plan.
• On March 4, 2026, 20,000 shares were sold at a weighted average price of $17.4959 per share.
• On March 5, 2026, 4,929 shares were sold at a weighted average price of $16.8061 per share.
• On March 6, 2026, 20,000 shares were sold at a weighted average price of $15.6836 per share.
• Following these transactions, Litchfield's direct beneficial ownership of MaxLinear common stock decreased to 343,435 shares from an initial 388,364 shares before these sales.
• The reported beneficial ownership includes 326 shares acquired under the Company's 2010 Employee Stock Purchase Plan on November 15, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. Insider sales under a pre-arranged 10b5-1 plan are generally considered routine and do not typically signal a change in the company's fundamental outlook.

Negatives

• The sale of shares by a key executive, even under a pre-arranged plan, could be interpreted by some investors as a lack of confidence, though this is often a personal financial decision.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under Rule 10b5-1 plans, are common for executives managing personal finances, diversifying portfolios, or for tax planning purposes. These pre-arranged plans typically mitigate the perception that the sale is based on new, negative material non-public information.

Stakeholder Impact

• Shareholders may note the reduction in direct beneficial ownership by a key executive, though the pre-arranged nature of the sales under a Rule 10b5-1 plan typically lessens concerns about management's view of future performance.

Key Dates

Recommendation

The reported transactions are routine insider sales executed under a Rule 10b5-1 trading plan, which are typically pre-scheduled and do not necessarily reflect a change in the executive's outlook on the company's future performance. As such, this filing alone does not provide a strong basis for a change in investment recommendation.

Keywords

MaxLinear, MXL, insider trading, Form 4, stock sale, CFO, Steven Litchfield, 10b5-1 plan